# Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression

> **NCT06506019** · PHASE1 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 30 (estimated)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** Psilocybin
- **DEVICE:** Functional MRI

## Key facts

- **NCT ID:** NCT06506019
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-09
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06506019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06506019, "Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06506019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*